Cytovia Therapeutics Licenses ProteoNic Technology

Cytovia Therapeutics Licenses Productivity-Boosting Manufacturing Technology for Its NK Engager Multifunctional Antibodies From ProteoNic Cytovia developing novel CAR NK cell therapy and NK engager antibodies for cancer   August 12, 2020 09:04 ET | Source: Cytovia Therapeutics NEW YORK and LEIDEN, the Netherlands, Aug. 12, 2020 (GLOBE NEWSWIRE) — Cytovia Therapeutics, Inc (Cytovia), an emerging biopharmaceutical company developing…